NORRIS MEDICINES LTD. - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
certificate under Regulation 74 (5) of SEBI LODR10-11-2022
10-11-2022
NORRIS MEDICINES LTD. - 524414 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vimal D ShahDesignation :- Managing Director / Whole Time Director07-11-2022
NORRIS MEDICINES LTD. - 524414 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
AGM Scrutinizer Report 202231-10-2022
NORRIS MEDICINES LTD. - 524414 - Extension Of Date Of Annual General Meeting Of The Company
Extension of date of Annual General Meeting of the Company29-09-2022
NORRIS MEDICINES LTD. - 524414 - Board Meeting Outcome for Application For Extension For Holding The Annual General Meeting Of The Company For The Financial Year Ended On March 31, 2022
We wish to inform you that the Board of Directors of the Company at its meeting held on Thursday, the 15th September, 2022 has granted its approval to make an application to Registrar of Companies for seeking extension of time to hold the Annual General Meeting for the financial year ended 31st March, 2022 by three months due to administrative reasons faced by the Company. Further, we would file necessary intimation and disclosure upon receipt of the decision from Registrar of Companies. Kindly take the same in your records and acknowledge.15-09-2022
NORRIS MEDICINES LTD. - 524414 - Intimation Of Book Closure For The Purpose Of Annual General Meeting
Intimation of Book Closure for the purpoase of Annual General Meeting31-08-2022
NORRIS MEDICINES LTD. - 524414 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting31-08-2022
NORRIS MEDICINES LTD. - 524414 - Submission Of Standalone Unaudited Financial Results In Compliance With Regulation 33 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 30/06/2022
Submission of Standalone Unaudited Financial Results in compliance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the quarter ended 30/06/202230-08-2022